101 results
Page 4 of 6
DEFA14A
0sex6ks5n9h5
29 May 20
Additional proxy soliciting materials
9:30am
8-K
EX-99.1
s960pmaznvr
11 May 20
Avenue Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights
9:00am
8-K
EX-99.1
8wuryt
23 Apr 20
Avenue Therapeutics Announces Presentation of IV Tramadol E-Posters
9:00am
8-K
EX-99.1
fpoqhggr u3wik
30 Mar 20
Avenue Therapeutics Reports Full Year 2019 Financial Results and Recent Corporate Highlights
9:01am
8-K
EX-99.1
dopm5sz742rk o7
13 Feb 20
Avenue Therapeutics Announces New Drug Application for IV Tramadol Accepted for Review by FDA
9:15am
8-K
EX-99.1
i12cn72bdurk2cx10e4l
11 Dec 19
Avenue Therapeutics Announces Submission of New Drug Application for IV Tramadol
9:00am
8-K
EX-99.1
czxlarcquifcs7
4 Nov 19
Avenue Therapeutics Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights
9:00am
8-K
EX-99.1
k1n2jn
14 Aug 19
Avenue Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
12:00am
8-K
EX-99.1
gtw tbfguqifef
3 Jun 19
Avenue Therapeutics Announces Positive Topline Data from Second Pivotal Phase 3 Study of Intravenous Tramadol in the Management of Postoperative Pain
8:45am
8-K
EX-99.1
yh5ochjj57 nvbb2p
13 May 19
Avenue Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
9:00am
8-K
EX-99.1
jqqv lml2k
12 Mar 19
Avenue Therapeutics Reports Full Year 2018 Financial Results and Recent Corporate Highlights
9:16am
DEFM14A
s0p4i53
21 Dec 18
Proxy related to merger
12:23pm
PREM14A
5a3ygy a7j9elqcz974q
11 Dec 18
Preliminary proxy related to merger
5:23pm